BioRestorative Therapies

brtxDISC (DiscImplantedStemCells) is an investigational non-surgical treatment for bulging and herniated lumbar discs that is intended for patients who have failed non-invasive procedures and face the prospect of surgery. The treatment involves culturing a patient's own stem cells and then delivering them via a proprietary medical device to the damaged region of the disc in an outpatient procedure. ThermoStem is a treatment using brown fat stem cells that is under development for metabolic disorders including diabetes and obesity. Initial preclinical research indicates that increased amounts of brown fat in the body may be responsible for additional caloric burning as well as reduced glucose and lipid levels. brtx-C Cosmetic is based on the development of a human cellular extract that has been demonstrated in in vitro skin studies to increase the production of collagen and fibronectin, which are proteins that are essential to combating the aging of skin. Potential cosmetic uses are being explored with third parties.
Type
Public
HQ
Melville, US
Founded
1997
Size (employees)
6 (est)
BioRestorative Therapies was founded in 1997 and is headquartered in Melville, US

BioRestorative Therapies Office Locations

BioRestorative Therapies has office in Melville
Melville, US

BioRestorative Therapies Metrics

BioRestorative Therapies Summary

Market capitalization

$18.2 m

Closing share price

$4.3
BioRestorative Therapies's current market capitalization is $18.2 m.

BioRestorative Therapies Financials

BioRestorative Therapies's revenue is $628.9 k in FY, 2015 which is a 51.2% increase from the previous period.
FY, 2014FY, 2015

Revenue

$416 k$628.9 k

Revenue growth, %

2309%51%

Cost of goods sold

$213.8 k$261.5 k

Gross profit

$202.2 k$367.4 k

Gross profit Margin, %

48.6%58.4%

Sales and marketing expense

$1.4 m$1.6 m

R&D expense

$1.4 m$2.1 m

General and administrative expense

$2.3 m$3.9 m

Operating expense total

$5.1 m$7.5 m

EBIT

($4.9 m)($7.2 m)

EBIT margin, %

(1183.3%)(1140.1%)

Interest expense

$285.3 k$263.6 k

Net Income

($5.6 m)($7.9 m)

BioRestorative Therapies Market Value History

BioRestorative Therapies Company Life

You may also be interested in